Health ❯ Chronic Diseases ❯ Diabetes

Type 2 Diabetes

Risk Factors Management Strategies Treatment Options Dietary Impact Prevention Strategies Prediabetes GLP-1 Medications Insulin Resistance Semaglutide Medication Management

Studies Point to Alcohol-Related Benefits as Costs Push Insurers to Tighten GLP‑1 Coverage

New observational analyses show fewer alcohol-related hospital admissions as budget models warn rapid GLP‑1 uptake could overwhelm insurer spending.

Diet Cola Dissolved Large Stomach Bezoar in Semaglutide Patient, Doctors Say

Prolonged Sitting Tied to Higher Cancer Risk, Study Finds

Large Penn Study Finds GLP‑1 Use Tied to Lower Breast Cancer Rates

Lifestyle Program Cuts 21-Year Risk of Multimorbidity in People With Prediabetes

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

Employers and Insurers Pull Back Coverage for GLP‑1 Weight‑Loss Drugs

New Adiposity Rules Would Label Most Americans as Obese

AOK Data Show Heart Attack Rates Falling in Bavaria and Mecklenburg-Vorpommern

Health Canada Approves Apotex’s Generic Ozempic, Opening Canada’s Market to Lower-Cost Semaglutide

Study in Punjabi Sikhs Identifies 36 Lipid–Gene Links to Diabetes and Heart Disease

VDR Gene Variant Tied to 19% Lower Diabetes Risk With High-Dose Vitamin D3

Keto Diet Lowers Pancreatic Stress Marker More Than Low-Fat Plan in Small Diabetes Trial

Ultra-Processed Foods Linked to Higher Thigh Muscle Fat in MRI Study

Lancet Analysis: Fatty Liver Disease Hits 1.3 Billion Globally, Could Reach 1.8 Billion by 2050

Short Bursts of Vigorous Activity Linked to Lower Risk of Eight Major Diseases

Metformin Lowers Blood Sugar Through Brain Circuit, Mouse Study Finds

Study Finds ‘Metabolically Healthy’ Childhood Obesity Still Carries High Long-Term Disease Risk

Obesity Care Shifts to Metabolic Health as Pakistani Doctors Report Earlier, Clustered Disorders

Mexico Regulators Warn of Illegal Online Tirzepatide Products